[Translation] A multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and safety of self-administered subcutaneous selatogrel in the prevention of all-cause mortality and in the treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction
本研究的主要目的是评估有急性心肌梗死(AMI)复发风险的受试者发生提示 AMI 症状后自行给予 selatogrel 的临床有效性。次要目的是评估自行给予 selatogrel 的安全性。其他目的是评估治疗策略的有效性,该策略有赖于受试者在出现疑似 AMI 症状时做出恰当、快速的反应。
[Translation] The primary objective of this study was to assess the clinical effectiveness of self-administration of selatogrel in subjects at risk of recurrence of acute myocardial infarction (AMI) following the development of symptoms suggestive of AMI. A secondary objective was to assess the safety of self-administration of selatogrel. Additional objectives were to assess the effectiveness of treatment strategies that depend on subjects responding appropriately and quickly to symptoms suspected of AMI.